HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Is selective abortion for a genetic disease an issue for the medical profession? A comparative study of Quebec and France.

Abstract
This article discusses the results of a study of the stand and attitudes of physicians from the Picardie, Nord-Pas-de-Calais region in France and the province of Quebec (Canada) regarding abortion following the diagnosis of a fetal anomaly by ultrasound, amniocentesis, or chorionic villus sampling. The study examined the degree of acceptability of abortion for several specific conditions as well as the physicians' perceptions of their role in the women's decision to abort. The study shows a consensus (over 75 per cent of the physicians surveyed) for aborting a fetus with trisomy 21. There is a similar consensus, except among Francophones in Quebec, for muscular dystrophy, cystic fibrosis, and Huntington disease. Conversely, there is no consensus (below 60 per cent) for several anomalies. In these cases, Quebec Anglophone physicians find abortion more acceptable than Quebec Francophone or French physicians. Concerning the role of the practitioners in the decision to abort, physicians in France tend to be much more directive than their overseas colleagues. Several hypotheses are suggested to explain the difference between the three groups surveyed.
AuthorsM Renaud, L Bouchard, O Kremp, L Dallaire, J F Labadie, J Bisson, A Trugeon
JournalPrenatal diagnosis (Prenat Diagn) Vol. 13 Issue 8 Pg. 691-706 (Aug 1993) ISSN: 0197-3851 [Print] England
PMID8284288 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Abortion, Therapeutic
  • Adult
  • Attitude of Health Personnel
  • Consensus
  • Decision Making
  • Female
  • France
  • Genetic Diseases, Inborn (diagnosis)
  • Humans
  • Internationality
  • Male
  • Physician's Role
  • Physicians
  • Pregnancy
  • Prenatal Diagnosis
  • Quebec
  • Surveys and Questionnaires

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: